
    
      The protocol was amended to clarify:

        -  Timeframe between each yearly scheduled visit,

        -  Number of additional booster doses a subject may receive depending on the RVNA level
           reached,

        -  Premature withdrawal from the study

        -  Exclusion criteria on scheduled visits

        -  That only SAEs experienced by subjects who received the booster must be reported

        -  Rewording of the protocol.
    
  